Article
The biology of normal and neoplastic stem cells in CML.
Leukemia & lymphoma - 1 Jan 1993
Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A
Abstract excerpt
Chronic myeloid leukemia (CML) has long served as a prototype malignancy for basic as well as clinical studies aimed at developing curative cancer treatment protocols. Well established features of chronic phase CML are its origin in a pluripotent stem cell, a now well defined molecular genetic basis involving the creation of a BCR-ABL fusion gene and evidence of resultant abnormalities in the mechanisms that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
